insurerrs

Major US insurer snubs Sarepta's Duchenne drug
BioPharma Dive
Mon, 10/10/16 - 09:18 am
Anthem
insurerrs
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 51